SCHEMBL19600426

SCHEMBL19600426

c1cncc(-c2cccc(-c3ccc4c(c3)Oc3cccc5c(-c6ccc(-c7c8ccccc8cc8ccccc78)cc6)ccc-4c35)c2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 7/20 0.41
GPR84 Q9NQS5 1/20 0.41
CYP11B2 P19099 6/20 0.40
CYP19A1 P11511 2/20 0.40
CYP17A1 P05093 1/20 0.40
PGR P06401 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
HSD17B1 P14061 1/20 0.37
CYP2B6 P20813 1/20 0.37
CYP2C19 P33261 1/20 0.37
HSD17B2 P37059 1/20 0.37
PIK3CA P42336 1/20 0.37
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19600401 0.89 KDM4E (0.46) CYP11B1GPR84CYP11B2CYP19A1CYP17A1
SCHEMBL16376421 0.82 CYP11B1 (0.41) CYP11B1GPR84CYP11B2CYP19A1CYP17A1
SCHEMBL23758551 0.82 CYP11B1 (0.39) CYP11B1GPR84CYP11B2CYP19A1CYP17A1
SCHEMBL17265385 0.81 CYP11B1 (0.44) CYP11B1GPR84CYP11B2CYP19A1CYP17A1
SCHEMBL23758680 0.79 MAPK1 (0.48) GPR84HSD17B1HSD17B2KDM4EALDH1A1
SCHEMBL16376406 0.79 KDM4E (0.40) GPR84KDM4EALDH1A1MAPTHPGD
SCHEMBL19600404 0.78 KDM4E (0.40) GPR84CYP1A2KDM4EALDH1A1HPGD
SCHEMBL19600399 0.78 GPR84 (0.41) GPR84CYP1A2CYP2D6CYP2C9HSD17B1
SCHEMBL16558533 0.77 MAPK1 (0.54) KDM4EALDH1A1HPGDMAPK1ATM
SCHEMBL19600397 0.77 ATM (0.42) GPR84HSD17B1HSD17B2PIK3CAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10573825-B2 Compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-25 US disclosed
US-20170331051-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-16 US disclosed
US-20170331051-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10573825-B2 Compound and organic light-emitting device including the same CRY1, CRY2, AOX1 CYP11B1 363/4885GPR84 2471/4885CYP11B2 441/4885
US-20170331051-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, AOX1 CYP11B1 363/4885GPR84 2471/4885CYP11B2 441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.